HIV resistance testing in the USA – a model for the application of pharmacogenomics in the clinical setting

Author： Blum Ronald A   Wylie Neil   England Tom   French Cynthia  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.2, 2005-03, pp. : 169-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

HIV testing: the cornerstone of HIV prevention efforts in the USA

By Heffelfinger James D   Owen S Michele   Hendry R Michael   Lansky Amy  

Future Virology, Vol. 6, Iss. 11, 2011-11 ,pp. : 1299-1317

Future Medicine

Access to resources Recommend Favorite

Routine antiretroviral resistance testing of value in HIV infections

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Guidelines for HIV-1 drug resistance testing

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Resistance to HIV Protease Inhibitors: Mechanisms and Clinical Consequences

By  

Current Drug Metabolism, Vol. 5, Iss. 4, 2004-08 ,pp. : 321-328

Bentham Science Publishers

Access to resources Recommend Favorite

Consider testing all therapy-naive patients for resistance in HIV

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite